Whilst the focus is on the pharmacutical market is all very positive , to me the most pleasing and new aspect to the report is:
Clinical market progress
In the clinical market, the Company are working with Quest Diagnostics in the United States to get the APAS® instrument into
routine use and connected to their laboratory systems. This will be an important demonstrating the benefits and efficiencies
of the technology, as a precursor to the potential roll out of the technology across the Quest Diagnostics group.
Whilst the focus is on the pharmacutical market is all very...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.7¢ |
Change
-0.001(5.56%) |
Mkt cap ! $30.01M | |||
| Open | High | Low | Value | Volume |
| 1.8¢ | 1.8¢ | 1.7¢ | $7.147K | 406.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 666706 | 1.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.8¢ | 610640 | 2 |
View Market Depth
| Last trade - 14.23pm 13/06/2025 (20 minute delay) ? |
| CC5 (ASX) Chart |